Our multidisciplinary team features experience in neuroendocrine tumors spanning more than half a century. Since the first description of Zollinger-Ellison syndrome at The Ohio State University in 1955, we have had a dedicated interest in these rare tumors.
We offer treatment options for all stages of disease including surgery, chemotherapy, chemoembolization, radioembolization, hormone therapy and experimental therapies.
Learn about clinical trials, our team of cancer experts and how to refer a patient at the links below.
How to Refer